The Association Bellinzona Institutes of Science (Bios+) is born

Bellinzona, September 15th, 2021 – the Foundations of the Institute for Research in Biomedicine (IRB) and the Institute of Oncology Research (IOR) presented the newly formed association Bellinzona Institutes of Science (Bios+), which was established by the two Institutes on July 21stwith the aim of promoting and coordinating research activities and creating scientific and organizational synergies ...
More

IOR research project receives important funding from the United States

The American Society of Hematology (ASH) - the world's leading association in the field of hematology - has awarded Dr. Adalgisa Condoluci, a researcher at the IOR, with the "ASH Global Research Award 2021". Dr. Condoluci is one of the twelve researchers selected for this honor, which aims to support research projects conducted by young researchers outside the United States and Canada. "The rec...
More

Open position for a Research Assistant / Postdoctoral Fellow

The Prostate Cancer Biology group directed by Dr. Giuseppina Carbone at the Institute of Oncology Research in Bellinzona, Switzerland, is seeking a Research Assistant / Postdoctoral Fellow. The Institute of Oncology Research (IOR) in Bellinzona, Switzerland, is a rapidly evolving, leading center for basic and translational research in oncology in Europe. The aim of our research is to decode the...
More

A molecular switch turns on the unfavorable evolution of prostate tumors

Background Prostate cancer is one of the most common malignancies and causes of mortality in men worldwide. About 50% of prostate tumors (ERG fusion-positive prostate cancers) harbor a fusion between the ERG gene and the promoter region of TMPRSS2 gene. This chromosomal rearrangement leads to abnormal production of ERG and promotes tumor progression. However, the mechanism by which ERG contribu...
More

Three-year postdoctoral fellowship in the Molecular Oncology Group directed by Prof. Andrea Alimonti at the IOR

A 3-year postdoctoral fellowship is available from September 1st, 2021 in the lab of Prof. Andrea Alimonti at IOR to study the role of senescence and the immune response in prostate cancer and aging and to develop novel effective therapies for the treatment of prostate cancer and other aging-related disorders. The Alimonti lab works on senescence and cancer immunology, in particular on the role pl...
More